CH512486A - Procédé de préparation de xanthines - Google Patents

Procédé de préparation de xanthines

Info

Publication number
CH512486A
CH512486A CH1134770A CH1134770A CH512486A CH 512486 A CH512486 A CH 512486A CH 1134770 A CH1134770 A CH 1134770A CH 1134770 A CH1134770 A CH 1134770A CH 512486 A CH512486 A CH 512486A
Authority
CH
Switzerland
Prior art keywords
xanthines
preparing
preparing xanthines
Prior art date
Application number
CH1134770A
Other languages
English (en)
Inventor
Schweiss Dieter
Marlin Long Loren
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of CH512486A publication Critical patent/CH512486A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH1134770A 1969-07-30 1970-07-27 Procédé de préparation de xanthines CH512486A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84626469A 1969-07-30 1969-07-30
US4559470A 1970-06-11 1970-06-11

Publications (1)

Publication Number Publication Date
CH512486A true CH512486A (fr) 1971-09-15

Family

ID=26722972

Family Applications (2)

Application Number Title Priority Date Filing Date
CH1134770A CH512486A (fr) 1969-07-30 1970-07-27 Procédé de préparation de xanthines
CH1034971A CH512487A (fr) 1969-07-30 1970-07-27 Procédé de préparation de xanthines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1034971A CH512487A (fr) 1969-07-30 1970-07-27 Procédé de préparation de xanthines

Country Status (8)

Country Link
AT (1) AT297021B (fr)
BE (1) BE754007A (fr)
CA (1) CA929519A (fr)
CH (2) CH512486A (fr)
DE (1) DE2037171C3 (fr)
FR (1) FR2059577B1 (fr)
GB (1) GB1280424A (fr)
NL (1) NL7011094A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0590919A1 (fr) * 1992-09-28 1994-04-06 Kyowa Hakko Kogyo Co., Ltd. Agents thérapeutiques pour la maladie de Parkinson
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2093403C (fr) * 1992-04-08 1999-08-10 Fumio Suzuki Agent de traitement de la maladie de parkinson

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317533A (en) * 1967-05-02 Theophylline derivatives

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484920A (en) * 1992-04-08 1996-01-16 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
US5587378A (en) * 1992-04-08 1996-12-24 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for Parkinson's disease
EP0590919A1 (fr) * 1992-09-28 1994-04-06 Kyowa Hakko Kogyo Co., Ltd. Agents thérapeutiques pour la maladie de Parkinson

Also Published As

Publication number Publication date
BE754007A (fr) 1970-12-31
DE2037171B2 (de) 1977-09-22
FR2059577A1 (fr) 1971-06-04
DE2037171C3 (de) 1978-05-18
CA929519A (en) 1973-07-03
DE2037171A1 (de) 1971-02-18
CH512487A (fr) 1971-09-15
GB1280424A (en) 1972-07-05
NL7011094A (fr) 1971-02-02
FR2059577B1 (fr) 1973-08-10
AT297021B (de) 1972-03-10

Similar Documents

Publication Publication Date Title
CH529751A (fr) Procédé de préparation de thiourées
CH527861A (fr) Procédé de préparation de polyesters
BE776014A (fr) Procédé de préparation de carbamates
CH529137A (fr) Procédé de préparation de tétrahydroisoquinoléins-carboxamides
CH526571A (fr) Procédé de préparation de 3-alcoxy-thianaphtène-2-carboxamides
CH503725A (fr) Procédé de préparation de 1-alkyl-2-aminométhylpyrrolidines
CH527271A (fr) Procédé de préparation de la rabélomycine
CH525188A (fr) Procédé de préparation de fluorénone-, fluorénol- et fluoréne-carboxamides bis-basiques
CH532605A (fr) Procédé de préparation de 2-phényl-3-acylbenzothiazolines
CH494779A (fr) Procédé de préparation de diorganochlorophosphines
CH513823A (fr) Procédé de préparation de nitroximes
CH519500A (fr) Procédé de préparation de pyrazolines
CH512487A (fr) Procédé de préparation de xanthines
CH519462A (fr) Procédé de préparation de N-alcoyl-diméthylamines
CH518886A (fr) Procédé de préparation de méthylcyclohexènes
CH501629A (fr) Procédé de préparation de dihydro-isoquinoléine-carboxamidoximes
CH529778A (fr) Procédé de préparation de nitrofuryl-oxadiazoleamide
CH522648A (fr) Procédé de préparation de benzo-lactames
CH498812A (fr) Procédé de préparation de N-Alcoxyalcoylène-N-Alcoyl urées
CH525888A (fr) Procédé de préparation de 2-pyridones
CH494233A (fr) Procédé de préparation de triazines
CH495426A (fr) Procédé de préparation de la triénine
CH523869A (fr) Procédé de préparation de peptides
CH526577A (fr) Procédé de préparation de spiro-adamantanethiazépinones
CH508576A (fr) Procédé de préparation du plicaténol

Legal Events

Date Code Title Description
PL Patent ceased